Bond Reaktiflerinin Kullanimi
13.7 Referanslar
1. Coons AH et al. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med
1941;47:200-202.
2. Nakane PK and Pierce GB Jr. Enzyme labeled antibodies: Preparations and applications for the localizations of
antigens. J Histochem Cytochem 1967; 14:929-931.
3. Elias JM, Gown AM, Nakamura RM, Wilbur DC, Herman GE, Jaffe ES, Battifora H, and Brigati J. Special report:
Quality control in immunohistochemistry. Am J Clin Path 1989; 92:836.
4. Nadji M and Morales AR. Immunoperoxidase techniques: a practical approach to tumor diagnosis. ASCP Press,
Chicago. 1986.
5. True LD ed. Atlas of Diagnostic Immunohistopathology. Lippincott, Philadelphia. 1990.
6. Gall JG, Pardue ML. Formation of RNA-DNA hybrid molecules in cytological preparation. Proceedings of the National
Academy of the Sciences of the United States of America. 1969;63:378-383.
7. Shi S-R, Gu J, and Taylor CR. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Eaton
Publishing, Natick. 2000
8. Miller RT, Swanson PE, and Wick MR. Fixation and epitope retrieval in diagnostic immunohistochemistry: a concise
review with practical considerations. Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):228-35.
9. Bancroft JD and Stevens A. Theory and Practice of Histological Techniques. 4th Edition. Churchill Livingstone, New
York. 1996.
10. Wolff et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations
for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med 2007; 131:18-43
11. Kiernan JA. Histological and Histochemical Methods: Theory and Practice. New York: Pergamon Press. 1981.
12. Sheehan DC. and Hrapchak BB. Theory and Practice of Histotechnology. St. Louis: C.V. Mosby Co. 1980.
13. Clinical Laboratory Improvement Amendments of 1988, Final Rule 57 FR 7163 February 28, 1992.
14. O'Leary TJ, Edmonds P, Floyd AD, Mesa-Tejada R, Robinowitz M, Takes PA, Taylor CR. Quality assurance for
immunocytochemistry; Proposed guideline. MM4-P. National Committee for Clinical Laboratory Standards (NCCLS).
Wayne, PA. 1997; 1-46.
15. Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven
monoclonal and three polyclonal antibodies. Progress in Surg Path 6:1-15. eds. Fenoglio-PreiserC, Wolff CM, Rilke
F. Field & Wood, Inc., Philadelphia.
16. College of American Pathologists (CAP) Certification Program for Immunohistochemistry. Northfield IL.
http://www.cap.org
17. Wilkinson DG. The theory and practice of in situ hybridisation. In: Wilkinson DG (ed.) In Situ Hybridization A
practical approach. 2nd Edition. New York: Oxford University Press, 1998, pp. 18-20
18. Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Lab Med 1983; 14:767.
19. Omata M, Liew CT, Ashcavai M, and Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B
surface antigen: a possible source of error in immunohistochemistry. Am J Clin Path 1980;73:626
20. Wilkinson DG. In situ hybridization: A practical approach. 2nd Edition. Oxford University Press, Oxford. 1998.
21. Weiss LM, Chen Y Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ
hybridization using oligonucleotide probes. The Journal of Histochemistry and Cytochemistry. 1991;39(9):1237-
1242.
22. Pontius CA, Murphy KA, Novis DA and Hansen AJ. CLIA Compliance Handbook: The Essential Guide for the Clinical
Laboratory. 2nd Edition. Washington G-2 Reports, New York. 2003.
Leica Bond Kullamm Kilavuzu Rev H01 © Leica Biosystems Melbourne 2009 259